Pharmacy and Poisons Board recalls Efinox nasal drops over label mix-up
By Charity Kilei |
The Board further advised all pharmacies, hospitals, and members of the public to immediately stop selling or purchasing the recalled batch.
The Pharmacy and Poisons Board has recalled a batch of Efinox nasal drops, due to labelling mix-ups.
The Board recalled Efinox 1% w/v Batch No. 82979 and Efinox 0.5% w/v Batch No. 82978, manufactured by Laboratory and Allied Ltd., Kenya, due to labelling mix-ups where the correct product was identified but the wrong strength was applied.
Keep reading
In a statement released on Friday, Dr F.M. Siyoi, the Chief Executive Officer, noted that "while the correct product was identified, the wrong strength was applied."
An investigation by Laboratory and Allied Ltd revealed that "there was likely a mix-up between 0.5% w/v and 1% w/v strengths of the Efinox Nasal Drops during the labelling and packing process of the above batches."
In light of this, the Board advises all pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public to immediately "stop the further distribution, sale, issuance, or use of the affected product batches. The products should be returned to the nearest healthcare facility or respective suppliers."
The Board urged the public to report any suspected cases of substandard medicines or adverse drug reactions to the nearest healthcare facility or directly to the agency.
Efinox is a nasal drop medication commonly used to treat conditions such as the common cold, allergic rhinitis (hay fever), and sinusitis.
It typically contains an active ingredient such as xylometazoline, which is a decongestant.
Xylometazoline works by constricting the blood vessels in the nasal passages, reducing swelling and congestion to make breathing easier.
Efinox is available in different strengths, such as 0.5% and 1% solutions, which are used to relieve nasal congestion.
Reader comments
Follow Us and Stay Connected!
We'd love for you to join our community and stay updated with our latest stories and updates. Follow us on our social media channels and be part of the conversation!
Let's stay connected and keep the dialogue going!
Latest News For You
